The reactivity of a mother’s autoantibodies to specific fetal brain protein patterns may predict the child’s diagnosis with a type of autism known as MAR ASD. MAR ASD was present in around 20% of kids with autism in Arkansas and Philadelphia samples and was linked to more significant autistic traits.
A new UC Davis Health study suggests that the increased rates of overdose and mental health crisis observed during the first year after opioid dose tapering persist through the second year. The study was published in JAMA Network Open.
An inhaled immunotherapy successfully treated cancer in some companion dogs as part of a clinical trial conducted by UC Davis oncology and veterinary researchers. Recently published study results show potential for fighting cancer in humans as well.
UC Davis Comprehensive Cancer Center has a new chief science officer and associate director for basic science. Xiao-Jing Wang comes from the University of Colorado Anshutz Medical Campus where she focused on skin as well as head and neck cancers
A study by UC Davis and UC San Francisco identified multiple barriers that family physicians navigate to provide abortion services to their patients. The barriers include lack of physician training and federal, state and institutional restrictions on providing medication abortion.
UC Davis Health physicians have performed the first single anesthesia diagnosis to treatment of lung cancer utilizing a fully robotic approach in the UC Health System. Procedure allows physicians to diagnose and remove lung cancer mass during single surgery.
A study led by UC Davis Cancer Center identified a binding protein in cancer cell’s nucleus, known as CHD4, as a critical agent keeping Kaposi's sarcoma-associated herpesvirus (KSHV) dormant and undetected by the body’s immune system. CHD4 is linked to cancer cell growth in many types of cancers.
UC Davis Comprehensive Cancer Center has launched the Center for Advancing Cancer Health Equity. The new center will work to improve health outcomes in underserved populations and help shape cancer-related policy decisions at the county, state, and national levels.
A new initiative called Pluralist will challenge the current paradigm and pursue equity in organ transplantation. The effort will place particular emphasis on communities of color in Sacramento and throughout California by using education intervention tools like social networks and digital media.
Racism facing Asian Americans is compounding existing cancer inequities. They are the first U.S. population group to experience cancer as the leading cause of death. A commentary in the Journal of the American Cancer Institute outlines the factors contributing to this.
Fragile X-associated tremor/ataxia syndrome (FXTAS) is a progressive genetic condition that causes movement challenges and cognitive decline. UC Davis MIND Institute researchers have shown, for the first time, how FXTAS can manifest in its earliest stages.
The UC Davis MIND Institute is launching a $4 million research program aimed at finding transformative therapies for ADNP syndrome, a rare genetic condition. A group of interdisciplinary researchers will evaluate multiple gene therapies for possible use.
Half of all women experience a false positive mammogram after 10 years of annual breast cancer screening with 3D mammography, a UC Davis-led study estimates. This risk was lower for women who had mammograms every other year. 3D screening showed slightly lower false positive results than standard mammography.
In a first of its kind clinical trial led by UC Davis Health, HOPE-2 showed that cellular therapy is safe and effective in stopping the deterioration of upper limb and heart functions in patients with late-stage Duchenne muscular dystrophy.
The UC Davis MIND Institute’s Leadership Education in Neurodevelopmental and Related Disabilities program is recruiting. Self-advocates, family members, researchers and clinicians who are passionate about improving the lives of people with autism and other neurodevelopmental disabilities are invited to apply.
The UC Davis MIND Institute has received funding from the Patient-Centered Outcomes Research Institute to create community partnerships to increase equity in research. The goal is to create a network that includes individuals with intellectual and developmental disabilities from diverse communities.
Researchers at the UC Davis MIND Institute have identified a gene linked to fetal brain development and autism. Their work shows that the gene is influenced by the mother’s early prenatal vitamins use and placental oxygen levels.
A long-term study by UC Davis MIND Institute researchers finds significant changes in brain development linked to anxiety in autistic children. The study, which included brain scans and interviews, also provides new evidence that supports forms of anxiety specific to autism.
A new UC Davis Health study found that taking bile acids or treatments that regulate their production may help control inflammation caused by psoriasis, a chronic skin condition.
The MIND Institute’s RISE-UP program is recruiting undergraduate students for its summer program. The unique opportunity is focused on students interested in serving historically underserved communities. They’ll learn more about research, clinical care, community support, neurodevelopmental disabilities and social justice.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right